Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions

Ophthalmic Epidemiology

Volumn 14, Issue 5, 2007, Pages 288-298

  Morris, Martha Savaria ^a   Jacques, Paul F ^a   Chylack, Leo T ^b   Hankinson, Susan E ^b,c   Willett, Walter C ^b,c   Hubbard, Larry D ^d   Taylor, Allen ^a  

^a TUFTS UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Aging; Antioxidant; Carotenoid; Eye; Macular Degeneration; Retina; Vitamin; Zinc

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; LYCOPENE; RETINOL; TRACE ELEMENT; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DRUSEN; EYE EXAMINATION; EYE FUNDUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RETINA MACULA AGE RELATED DEGENERATION; RETINA PIGMENT DEGENERATION; UNITED STATES;

AGED; ANTIOXIDANTS; COHORT STUDIES; DIET; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MACULAR DEGENERATION; MICRONUTRIENTS; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; PREVALENCE; RETINAL DISEASES; RETINAL DRUSEN; TIME FACTORS; ZINC;

EID: 36249031619     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580601186759     Document Type: Article

References (42)

1. Quillen DA. Common causes of vision loss in elderly patients. Am Fam Physician. 1999;60:99-108.
2. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in amultiracial United States population: The National Health and Nutrition Examination Survey III. Ophthalmology. 1999;106:1056-1065.
3. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
4. Munoz B, West SK. Blindness and visual impairment in the Americas and the Caribbean. Br J Ophthalmol. 2002;86:498-504.
5. The Age-Related Eye Disease Study (AREDS): Design implications. AREDS report no. 1. Control Clin Trials. 1999;20:573-600.
6. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
7. Mares-Perlman J, Klein R. Diet and Age-related Macular Degeneration. In: Taylor A, ed. Nutritional and Environmental Influences on the Eye. Boca Raton, FL: CRC Press LLC, 1999;181-214.
8. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
9. Wald G. Human vision and the spectrum. Science. 1945;101:653-658.
10. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28-40.
11. Krinsky NI. Possible biologic mechanisms for a protective role of xanthophylls. J Nutr. 2002;132:540S-542S.
12. Alves-Rodrigues A, Shao A. The science behind lutein. Toxicol Lett. 2004;150:57-83.
13. Schlach W. The carotenoids of the human retina. In: Taylor A, ed. Nutritional and Environmental Influences on the Eye. Boca Raton, FL: CRC, 1999;215-250.
14. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. Zinc and the eye. J Am Coll Nutr. 2001;20:106-118.
15. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol.1988;106:192-198.
16. Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44:2461-2465.
17. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based casecontrol study. Arch Ophthalmol. 1995;113:1518-1523.
18. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA.1994;272:1413-1420.
19. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148:204-214.
20. Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology. 2002;109:2272-2278.
21. Smith W, Mitchell P, Webb K, Leeder SR. Dietary antioxidants and age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology. 1999;106:761-767.
22. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004;122:883-892.
23. Cho E, Stampfer MJ, Seddon JM, et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol. 2001;11:328-336.
24. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third National Health and Nutrition Examination Survey. Am J Epidemiol. 2001;153:424-432.
25. Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol.1996;114:991-997.
26. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in agerelated macular degeneration: Pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol. 1999;44:1-29.
27. Jacques PF, Chylack LT, Jr., Hankinson SE, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol. 2001;119:1009-1019.
28. Willett WC. Nutritional Epidemiology. New York: Oxford University Press, 1998.
29. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willett WC. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr. 2003;77:1390-1399.
30. Willett WC. Nutritional Epidemiology. New York: Oxford University Press, 1998.
31. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128-1134.
32. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of agerelated macular degeneration. Am J Ophthalmol. 2004;137:486-495.
33. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128:700-710.
34. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol. 1999;117:1384-1390.
35. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Tenyear incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 2002;109:1767-1779.
36. Delamere NA. Ascorbic acid and the eye. Subcell Biochem. 1996;25:313-329.
37. Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-1562.
38. Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res. 2000;71:239-245.
39. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci.2000;41:3322- 3326.
40. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: A casecontrol study. Invest Ophthalmol Vis Sci. 2001;42:235-240.
41. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.Ophthalmology. 2002;109:1780-1787.
42. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42:439-446.